Cardiovascular Gastro/Intestinal Gynecology Neuro Orthopedics Ophthalmology Pulmonary Urology Vascular

Confluent Surgical, Inc. is developing hydrogel polymer and delivery technologies for easy application of adhesion barriers and vascular embolic agents. Ekos was formed to commercialize products based on the innovative research of Drs. Shunro and Katsuro Tachibana of Fukuoka University School of Medicine in Japan. Ekos applies low energy, localized ultrasound to facilitate, enhance, control or activate drugs at a targeted tissue site. The company's focus is to enhance thrombolysis in stroke. Provasis Therapeutics, Inc. has developed novel and proprietary materials for patients with cerebrovascular, cardiovascular and cancerous tumors. Provasis's first products are a novel compound for cerebrovascular AVMs and cancer tumors, and a second compound for cerebrovascular aneurisms. During February 2005 the assets of Provasis Therapeutics, Inc. were acquired by Boston Scientific Corporation. Seacoast Technologies, Inc. has developed hypothermia-based therapies to protect patients who suffer from various neurological emergencies, including head trauma and stroke.